iShares Biotechnology ETF (NASDAQ:IBB) Stock Position Increased by Milestone Investment Advisors LLC

Milestone Investment Advisors LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 36.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,730 shares of the financial services provider’s stock after buying an additional 1,786 shares during the period. Milestone Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $980,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Avidian Wealth Enterprises LLC increased its position in shares of iShares Biotechnology ETF by 13.6% during the 3rd quarter. Avidian Wealth Enterprises LLC now owns 2,498 shares of the financial services provider’s stock valued at $364,000 after purchasing an additional 300 shares during the period. MinichMacGregor Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth about $221,000. James J. Burns & Company LLC raised its position in iShares Biotechnology ETF by 20.4% in the third quarter. James J. Burns & Company LLC now owns 2,051 shares of the financial services provider’s stock worth $298,000 after acquiring an additional 347 shares in the last quarter. Clarity Capital Partners LLC acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at about $206,000. Finally, Quintet Private Bank Europe S.A. boosted its position in shares of iShares Biotechnology ETF by 20.7% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 14,752 shares of the financial services provider’s stock valued at $2,148,000 after purchasing an additional 2,533 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.5 %

NASDAQ IBB opened at $145.06 on Wednesday. iShares Biotechnology ETF has a 12 month low of $113.56 and a 12 month high of $150.57. The company’s 50 day simple moving average is $144.86 and its 200 day simple moving average is $140.84.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.